Regulation of immune response to influenza by innate immunity.
通过先天免疫调节对流感的免疫反应。
基本信息
- 批准号:7275926
- 负责人:
- 金额:$ 45.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesAntigenic VariationB-LymphocytesBioterrorismCD4 Positive T LymphocytesCapsid ProteinsCellsComplementCore ProteinCytotoxic T-LymphocytesDevelopmentEffector CellGenerationsGoalsHealthHelper-Inducer T-LymphocyteHemagglutininHumanImmune responseImmune systemImmunoglobulin MIn VitroInflammationInfluenzaLungMammalsMemoryMemory B-LymphocyteMolecularNatural ImmunityNeuraminidaseNucleocapsidRegulationRoleSystemT-LymphocyteThinkingVaccinationVirus Diseasesfluin vivoinfluenzaviruslymph nodesneutralizing antibodyresponsetrafficking
项目摘要
DESCRIPTION (provided by applicant): Influenza virus represents a major worldwide health problem as well as a potential agent for use in bioterrorism. Of the 3 known strains, influenza A is probably the best studied as it infects not only humans but other mammals and can be adapted to animal models. The major antigenic targets-hemagglutinin and neuraminidase- undergo structural changes such that antibodies formed against one strain generally are not protective with a related strain. Because of this "antigenic variation", neutralizing antibodies are not long lasting and necessitate annual vaccination. A cytotoxic T cell response to inner core proteins such as the nucleocapsid that are more conserved; or a antibody that targets conserved regions of the outer coat proteins would be desirable targets for generation of long lasting memory responses. The overall goal of this project is to investigate the cellular and molecular mechanisms underlying the role for innate immunity (complement system and natural IgM) in development of influenza-specific effector and memory T and B cells. Three specific aims are proposed: (i) Examine the role of complement C3 in the activation and expansion of influenza-specific effector and memory CDS T cells. (ii) Examine the role of complement C3 in the development of memory B cells, (iii) Examine the role of natural IgM in host innate and adaptive response to influenza.
描述(由申请人提供):流感病毒是一个主要的全球性健康问题,也是一种用于生物恐怖主义的潜在制剂。在已知的3种毒株中,甲型流感可能是研究得最好的,因为它不仅感染人类,还感染其他哺乳动物,并且可以适应动物模型。主要的抗原靶点-血凝素和神经氨酸酶-经历结构变化,使得针对一种菌株形成的抗体通常不具有相关菌株的保护性。由于这种“抗原变异”,中和抗体不持久,需要每年接种疫苗。细胞毒性T细胞对更保守的内核蛋白(例如核衣壳)的反应;或者针对外壳蛋白保守区域的抗体将是产生持久记忆反应的理想靶点。本项目的总体目标是研究先天免疫(补体系统和天然IgM)在流感特异性效应和记忆T和B细胞发育中的作用的细胞和分子机制。提出了三个具体目标:(i)检查补体C3在流感特异性效应和记忆CDS T细胞的活化和扩增中的作用。(ii)检查补体C3在记忆B细胞发育中的作用。(iii)检查天然IgM在宿主对流感的先天性和适应性应答中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Craig Carroll其他文献
Michael Craig Carroll的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Craig Carroll', 18)}}的其他基金
Astrocyte-neuron communication and vulnerability to mental illness
星形胶质细胞-神经元通讯和患精神疾病的脆弱性
- 批准号:
10686440 - 财政年份:2022
- 资助金额:
$ 45.98万 - 项目类别:
Neuroimmune mechanisms of adolescent brain development and vulnerability
青少年大脑发育和脆弱性的神经免疫机制
- 批准号:
10686442 - 财政年份:2022
- 资助金额:
$ 45.98万 - 项目类别:
Contributions of human C4A overexpression to schizophrenia pathogenesis.
人类 C4A 过度表达对精神分裂症发病机制的贡献。
- 批准号:
10686441 - 财政年份:2022
- 资助金额:
$ 45.98万 - 项目类别:
Evolution of autoreactive GC and epitope spreading in lupus
狼疮自身反应性GC和表位扩散的演变
- 批准号:
10736511 - 财政年份:2018
- 资助金额:
$ 45.98万 - 项目类别:
Evolution of autoreactive GC and epitope spreading in lupus
狼疮自身反应性GC和表位扩散的演变
- 批准号:
10399632 - 财政年份:2018
- 资助金额:
$ 45.98万 - 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
- 批准号:
10433932 - 财政年份:2018
- 资助金额:
$ 45.98万 - 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
- 批准号:
10196940 - 财政年份:2018
- 资助金额:
$ 45.98万 - 项目类别:
Neural-immune mechanisms and synaptic connectivity in psychiatric illness
精神疾病中的神经免疫机制和突触连接
- 批准号:
9280281 - 财政年份:2017
- 资助金额:
$ 45.98万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 45.98万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 45.98万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 45.98万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 45.98万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 45.98万 - 项目类别:














{{item.name}}会员




